Oleanolic acid inhibits osteosarcoma cell proliferation and invasion by suppressing the SOX9/Wnt1 signaling pathway

Xianming Chen1, Yulin Zhang2, Sen Zhang1

  • 1Department of Osteopathic Medicine, Daping Hospital, Army Medical University, Chongqing 400042, P.R. China.

Insights

Oleanolic acid (OA) effectively inhibits osteosarcoma cell proliferation and invasion by targeting the SOX9/Wnt1 signaling pathway. This natural compound reduces cell viability, migration, and increases apoptosis in osteosarcoma cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Osteosarcoma is a prevalent bone cancer in children and adolescents.
  • The SOX9/Wnt1 signaling pathway is implicated in osteosarcoma metastasis.
  • Oleanolic acid (OA) is being investigated for its potential anti-cancer properties.

Purpose of the Study:

  • To investigate the effect of oleanolic acid (OA) on osteosarcoma cell proliferation and invasion.
  • To determine if OA modulates the SOX9/Wnt1 signaling pathway in osteosarcoma cells.

Main Methods:

  • Osteosarcoma cell lines (KHOS, U2OS) and a normal osteoblastic cell line (hFOB1.19) were used.
  • Cell viability, proliferation, cell cycle, migration (wound healing), and invasion (Transwell assay) were analyzed.
  • Apoptosis and protein expression of SOX9 and Wnt1 were assessed.
  • SOX9 small interfering RNA (siRNA) was used to confirm pathway involvement.

Main Results:

  • OA significantly inhibited cell viability, proliferation, and S-phase cell cycle progression in osteosarcoma cells.
  • OA reduced cell migration and invasion, and increased apoptosis in osteosarcoma cells.
  • OA treatment decreased SOX9 and Wnt1 protein expression, with Wnt1 downregulation reversed by SOX9 siRNA.

Conclusions:

  • Oleanolic acid (OA) demonstrates potent anti-cancer effects against osteosarcoma.
  • OA suppresses osteosarcoma cell proliferation, invasion, and migration by inhibiting the SOX9/Wnt1 pathway.
  • OA represents a potential therapeutic agent for osteosarcoma treatment.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.5K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.8K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.5K